Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
May 26, 2004 (San Francisco) — Patients in the acute stage of myocardial infarction (MI) may not benefit from implantable cardioverter defibrillator (ICD) therapy. The results presented here in a late ...
Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.
The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing ...
(HealthDay News) — For adults with ischemic or nonischemic cardiomyopathy, implantable cardioverter defibrillator (ICD) therapy is associated with reduced incidence of sudden and all-cause death ...
Rochester, NY - MI patients with disease severity ranging from New York Heart Association (NYHA) class 1 to 3 benefited from an implantable cardioverter-defibrillator (ICD), according to a secondary ...
"Appropriately selected patients with NICM have the potential to benefit from primary prevention ICD therapy…Besides consideration of ICD placement, attention to guideline-directed medical therapy and ...
2020 DEC 01 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Fresh data on Life Science Research are presented in a new report. According to news originating from ...
New report in the Canadian Journal of Cardiology shows that rural patients have lower referral rates and higher refusal rates for implantable cardioverter defibrillators, a standard device therapy for ...
SAN FRANCISCO, CA—A primary prevention implantable cardioverter-defibrillator (ICD) seems to lessen the risk of dying among patients with heart failure and reduced ejection fraction (HFrEF) even on ...
Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...
Hosted on MSN
Implantable cardioverter defibrillators did not improve mortality in selected heart-attack patients
Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback